{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:06:43Z","timestamp":1761581203658,"version":"3.40.4"},"publisher-location":"Chichester, UK","reference-count":77,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006466.pub4","type":"reference-entry","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T14:00:31Z","timestamp":1401890431000},"source":"Crossref","is-referenced-by-count":7,"title":["Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation"],"prefix":"10.1002","author":[{"given":"Elie A","family":"Akl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Kahale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Terrenato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor E D","family":"Yosuico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Sperati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD006466.pub4-BIB1|cit1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1200\/JCO.1989.7.8.993","article-title":"A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B","volume":"7","author":"Chahinian","year":"1989","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01831705","article-title":"The first international urokinase\/warfarin trial in colorectal cancer","volume":"9","author":"Daly","year":"1991","journal-title":"Clinical & Experimental Metastasis"},{"issue":"8902","key":"10.1002\/14651858.CD006466.pub4-BIB3|cit3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","article-title":"Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer","volume":"343","author":"Levine","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006466.pub4-BIB4|cit4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1538-7836.2012.04693.x","article-title":"A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer","volume":"10","author":"Levine","year":"2012","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD006466.pub4-BIB5|cit5","series-title":"XXII Congress of the International Society on Thrombosis and Haemostasis","first-page":"PP","article-title":"Apixaban in patients with metastatic cancer: a randomized phase II feasibility study","author":"Liebman","year":"2009"},{"issue":"11","key":"10.1002\/14651858.CD006466.pub4-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1200\/JCO.1997.15.11.3378","article-title":"Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study","volume":"15","author":"Maurer","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006466.pub4-BIB7|cit7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/thx.34.1.113","article-title":"Anticoagulants in the treatment of small cell carcinoma of the bronchus","volume":"34","author":"Stanford","year":"1979","journal-title":"Thorax"},{"issue":"10","key":"10.1002\/14651858.CD006466.pub4-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/1097-0142(19840515)53:10<2046::AID-CNCR2820531007>3.0.CO;2-F","article-title":"Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75","volume":"53","author":"Zacharski","year":"1984","journal-title":"Cancer"},{"issue":"8","key":"10.1002\/14651858.CD006466.pub4-BIB9|cit9","first-page":"831","article-title":"Effect of warfarin on survival in small cell carcinoma of the lung. Veterans administration study No. 75","volume":"245","author":"Zacharski","journal-title":"1981"},{"key":"10.1002\/14651858.CD006466.pub4-BIB10|cit10","first-page":"179","article-title":"Aggressive combination chemotherapy, chest and brain irradiation and warfarin for the treatment of limited disease of small cell lung cancer (SCLC)","volume":"6","author":"Aisner","year":"1987","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD006466.pub4-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1200\/JCO.1992.10.8.1230","article-title":"Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study","volume":"10","author":"Aisner","year":"1992","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD006466.pub4-BIB12|cit12","first-page":"62","article-title":"Coumarin (1,2-benzopyrone) - new findings for tumor therapy","volume":"45","author":"Anonymous","year":"1994","journal-title":"Medizinische Welt"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB13|cit13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00000421-199502000-00003","article-title":"Cancer incidence and mortality in patients with heart disease. Effect of oral anticoagulant therapy","volume":"18","author":"Carpi","year":"1995","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006466.pub4-BIB14|cit14","first-page":"C","article-title":"Evaluation of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer (SCCL)","author":"Chahinian","year":"1984","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD006466.pub4-BIB15|cit15","first-page":"191","article-title":"Update on anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer (SCCL)","volume":"4","author":"Chahinian","year":"1985","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD006466.pub4-BIB16|cit16","first-page":"4827","article-title":"Clinical and pharmacokinetic effects of combined warfarin and 5-fluorouracil in advanced colon cancer","volume":"42","author":"Chlebowski","year":"1982","journal-title":"Cancer Research"},{"issue":"4","key":"10.1002\/14651858.CD006466.pub4-BIB17|cit17","first-page":"172","article-title":"Low dosage chemoimmunotherapy plus warfarin in metastatic breast cancer","volume":"149","author":"D'Souza","year":"1980","journal-title":"Irish Journal of Medical Science"},{"issue":"10","key":"10.1002\/14651858.CD006466.pub4-BIB18|cit18","first-page":"385","article-title":"Cyclophosphamide, prednisone, staphage lysate and warfarin in disseminated breast cancer","volume":"73","author":"D'Souza","year":"1980","journal-title":"Irish Medical Journal"},{"key":"10.1002\/14651858.CD006466.pub4-BIB19|cit19","first-page":"18S","article-title":"Increased levels of inflammatory mediators in lung cancer and their modulation by oral anticoagulant treatment","volume":"24","author":"Demir","year":"2006","journal-title":"Journal of Clinical Oncology, ASCO Annual Meeting Proceedings. Post-Meeting edition"},{"key":"10.1002\/14651858.CD006466.pub4-BIB20|cit20","series-title":"Journal of Clinical Oncology, ASCO Annual Meeting Proceedings","article-title":"Protein chip array profiling and markers of inflammation and thrombin generation in plasma samples from lung cancer patients and their modulation by chemotherapy with or without warfarin anticoagulation","author":"Demir","year":"2007"},{"key":"10.1002\/14651858.CD006466.pub4-BIB21|cit21","first-page":"131","article-title":"Coumarin and cimetidine in the treatment of metastatic renal cell carcinoma","volume":"7","author":"Herrmann","year":"1988","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD006466.pub4-BIB22|cit22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.annonc.a057801","article-title":"Phase II trial of coumarin and cimetidine in advanced renal cell carcinoma","volume":"1","author":"Herrmann","year":"1990","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB23|cit23","first-page":"29","article-title":"Lack of effect of warfarin (NSC-59813) alone or in combination with 5-fluorouracil (NSC-19893) on primary and metastatic L1210 leukemia and adenocarcinoma 755","volume":"55","author":"Higashi","year":"1971","journal-title":"Cancer Chemotherapy Reports - Part 1"},{"key":"10.1002\/14651858.CD006466.pub4-BIB24|cit24","series-title":"American Society of Hematology, Annual Meetings and Exposition 2294","article-title":"Inflammatory and thrombotic mediators in small cell lung carcinoma: potential role in thromboembolic complications","author":"Hoppensteadt","year":"2011"},{"issue":"2","key":"10.1002\/14651858.CD006466.pub4-BIB25|cit25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.1993.11.2.383","article-title":"Warfarin and small-cell lung cancer","volume":"11","author":"Huber","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD006466.pub4-BIB26|cit26","first-page":"A873","article-title":"Coumarin and cimetidine as active agents in melanoma and renal-cell carcinoma","volume":"32","author":"Hutchins","year":"1984","journal-title":"Clinical Research"},{"key":"10.1002\/14651858.CD006466.pub4-BIB27|cit27","first-page":"P10","article-title":"Inflammatory and thrombotic mediators in small cell lung carcinoma: potential role in thromboembolic complications","author":"Khan","year":"2012","journal-title":"Hamostaseologie"},{"issue":"Suppl","key":"10.1002\/14651858.CD006466.pub4-BIB28|cit28","first-page":"971","article-title":"Cimetidine and coumarin treatment of metastatic renal cell carcinoma","volume":"116","author":"Kokron","year":"1990","journal-title":"Journal of Cancer Research & Clinical Oncology"},{"key":"10.1002\/14651858.CD006466.pub4-BIB29|cit29","first-page":"10","article-title":"Randomised study in metastatic renal cell cancer: coumarin versus coumarin and cimetidine","volume":"22 Suppl 1","author":"Kokron","year":"1993","journal-title":"Journal of the Irish Colleges of Physicians & Surgeons"},{"issue":"5","key":"10.1002\/14651858.CD006466.pub4-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/1097-0142(19930301)71:5<1741::AID-CNCR2820710507>3.0.CO;2-Q","article-title":"No effect of an antiaggregant treatment with aspirin in small-cell lung-cancer treated with Ccavp16 chemotherapy - results from a randomized clinical-trial of 303 patients","volume":"71","author":"Lebeau","year":"1993","journal-title":"Cancer"},{"issue":"9","key":"10.1002\/14651858.CD006466.pub4-BIB31|cit31","first-page":"1258","article-title":"Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies","volume":"90","author":"Lecumberri","year":"2005","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD006466.pub4-BIB32|cit32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJM199902043400503","article-title":"Lack of effect of coumarin in women with lymphedema after treatment for breast cancer","volume":"340","author":"Loprinzi","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD006466.pub4-BIB33|cit33","first-page":"94B","article-title":"Low dose warfarin decreases central line thrombosis and tissue plasminogen activator (TPA) utilization in cancer patients but does not improve overall survival","volume":"98","author":"Macareo","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB34|cit34","first-page":"91","article-title":"Treatment of non-small cell lung cancer with coumarin and cimetidine","volume":"71","author":"Marshall","year":"1987","journal-title":"Cancer Treatment Reports"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB35|cit35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00254109","article-title":"Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study","volume":"24","author":"Marshall","year":"1989","journal-title":"Cancer Chemotherapy & Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD006466.pub4-BIB36|cit36","first-page":"1317","article-title":"Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma: editorial comment","volume":"144","author":"Marshall","year":"1990","journal-title":"Journal of Urology"},{"issue":"10","key":"10.1002\/14651858.CD006466.pub4-BIB37|cit37","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/bjs.1800741005","article-title":"Warfarin inhibition of metastasis: the role of anticoagulation","volume":"74","author":"McCulloch","year":"1987","journal-title":"British Journal of Surgery"},{"issue":"11","key":"10.1002\/14651858.CD006466.pub4-BIB38|cit38","first-page":"325A","article-title":"Survival and outcome data in patients with adenocarcinoma of the prostate receiving warfarin therapy","volume":"102","author":"Moazzam","year":"2003","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006466.pub4-BIB39|cit39","first-page":"12","article-title":"Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma","volume":"22 Suppl 1","author":"Mohler","year":"1993","journal-title":"Journal of the Irish Colleges of Physicians & Surgeons"},{"key":"10.1002\/14651858.CD006466.pub4-BIB40|cit40","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/BF01377123","article-title":"Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma","volume":"120 Suppl","author":"Mohler","year":"1994","journal-title":"Journal of Cancer Research & Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD006466.pub4-BIB41|cit41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/oxfordjournals.annonc.a059097","article-title":"Randomised study using IFN-alpha versus IFN-alpha plus coumarin and cimetidine for treatment of advanced renal cell cancer","volume":"6","author":"Sagaster","year":"1995","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB42|cit42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(24)01481-9","article-title":"The complex effects of heparins on cancer progression and metastasis in experimental studies","volume":"53","author":"Smorenburg","year":"2001","journal-title":"Pharmacological Review"},{"issue":"8","key":"10.1002\/14651858.CD006466.pub4-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1046\/j.1538-7836.2003.00293.x","article-title":"Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation","volume":"1","author":"Taliani","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD006466.pub4-BIB44|cit44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1538-7836.2004.0584u.x","article-title":"Vitamin K antagonists and cancer: reply to rebuttal","volume":"2","author":"Taliani","year":"2004","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD006466.pub4-BIB45|cit45","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1200\/jco.2011.29.15_suppl.2553","article-title":"Procoagulant and inflammatory mediators in small cell lung carcinoma: potential role in thromboembolic complications","volume":"29 Suppl","author":"Thethi","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD006466.pub4-BIB46|cit46","first-page":"41","article-title":"Warfarin as maintenance therapy for cancer","volume":"29","author":"Thornes","year":"1972","journal-title":"Journal of the Irish Colleges of Physicians and Surgeons"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB47|cit47","first-page":"83","article-title":"Oral anticoagulant therapy of human cancer","volume":"5","author":"Thornes","year":"1974","journal-title":"Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB48|cit48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/1097-0142(197501)35:1<91::AID-CNCR2820350114>3.0.CO;2-Z","article-title":"Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulants","volume":"35","author":"Thornes","year":"1975","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD006466.pub4-BIB49|cit49","first-page":"187","article-title":"Prevention of recurrence of kaposis sarcoma, breast-cancer and melanoma by coumarin","volume":"153","author":"Thornes","year":"1984","journal-title":"Irish Journal of Medical Science"},{"issue":"5","key":"10.1002\/14651858.CD006466.pub4-BIB50|cit50","first-page":"431","article-title":"Prevention of early recurrence of high risk malignant melanoma by coumarin","volume":"15","author":"Thornes","year":"1989","journal-title":"European Journal of Surgical Oncology"},{"key":"10.1002\/14651858.CD006466.pub4-BIB51|cit51","first-page":"17","article-title":"Prevention of recurrence of malignant melanoma by coumarin (1,2-benzopyrone)","volume":"22 Suppl 1","author":"Thornes","year":"1993","journal-title":"Journal of the Irish Colleges of Physicians & Surgeons"},{"key":"10.1002\/14651858.CD006466.pub4-BIB52|cit52","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1007\/BF01377122","article-title":"Treatment with coumarin to prevent or delay recurrence of malignant melanoma","volume":"120 Suppl","author":"Thornes","year":"1994","journal-title":"Journal of Cancer Research & Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD006466.pub4-BIB53|cit53","first-page":"99","article-title":"Ten-year survival in patients receiving anticoagulant therapy for breast cancer","volume":"29","author":"Tiska-Rudman","year":"2001","journal-title":"Libri Oncologici"},{"issue":"3","key":"10.1002\/14651858.CD006466.pub4-BIB54|cit54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1200\/JCO.1989.7.3.402","article-title":"Activity of coumarin and cimetidine in metastatic renal cell carcinoma","volume":"7","author":"Venook","year":"1989","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB55|cit55","first-page":"xx","article-title":"Clinical trial of warfarin in cancer","volume":"42","author":"Zacharski","year":"1979","journal-title":"Thrombosis & Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD006466.pub4-BIB56|cit56","first-page":"302","article-title":"Effect of warfarin therapy on survival in cancer - final report of VA Cooperative Study #75","volume":"66","author":"Zacharski","year":"1982","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD006466.pub4-BIB57|cit57","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-97-5-784_2","article-title":"Warfarin and cancer","volume":"97","author":"Zacharski","year":"1982","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD006466.pub4-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1990.8.7.1282","article-title":"Warfarin for small-cell lung cancer: why not?","volume":"8","author":"Zacharski","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD006466.pub4-BIB59|cit59","first-page":"20","article-title":"Warfarin therapy for cancer","volume":"22 Suppl 1","author":"Zacharski","year":"1993","journal-title":"Journal of the Irish Colleges of Physicians & Surgeons"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB60|cit60","first-page":"173","article-title":"A rebuttal: vitamin K antagonists and cancer survival","volume":"88","author":"Zacharski","year":"2002","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD006466.pub4-BIB61|cit61","unstructured":"A Randomized, Double-blind, Placebo-controlled Study of Apixaban for the Prevention of Thromboembolic Events in Patients Undergoing Treatment for Advanced Cancer: a Phase 2 Pilot Study Ongoing study"},{"issue":"12","key":"10.1002\/14651858.CD006466.pub4-BIB62|cit62","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006466.pub2","article-title":"Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation","author":"Akl","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006466.pub4-BIB63|cit63","article-title":"Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation","author":"Akl","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006466.pub4-BIB64|cit64","doi-asserted-by":"crossref","first-page":"e57132","DOI":"10.1371\/journal.pone.0057132","article-title":"Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers","volume":"8","author":"Akl","year":"2013","journal-title":"PLoS One"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006466.pub4-BIB65|cit65","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1002\/14651858.CD006466.pub4-BIB66|cit66","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"issue":"26","key":"10.1002\/14651858.CD006466.pub4-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006466.pub4-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jclinepi.2013.03.014","article-title":"Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers","volume":"66","author":"Ebrahim","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD006466.pub4-BIB69|cit69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-995829","article-title":"Hemostasis and malignancy","volume":"24","author":"Francis","year":"1998","journal-title":"Seminars in Thrombosis & Hemostasis"},{"key":"10.1002\/14651858.CD006466.pub4-BIB70|cit70","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006466.pub4-BIB71|cit71","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD006466.pub4-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1378\/chest.12-1362","article-title":"Moving toward a more ideal anticoagulant: the oral direct thrombin and factor Xa inhibitors","volume":"143","author":"King","year":"2013","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD006466.pub4-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1046\/j.1538-7836.2003.00275.x","article-title":"From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer","volume":"1","author":"Levine","year":"2003","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"12","key":"10.1002\/14651858.CD006466.pub4-BIB74|cit74","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/j.1538-7836.2004.01011.x","article-title":"Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway","volume":"2","author":"Miller","year":"2004","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"26","key":"10.1002\/14651858.CD006466.pub4-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJM200006293422604","article-title":"Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial","volume":"342","author":"Schulman","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD006466.pub4-BIB76|cit76","first-page":"831","article-title":"Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75","volume":"245","author":"Zacharski","journal-title":"1981"},{"issue":"5","key":"10.1002\/14651858.CD006466.pub4-BIB77|cit77","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/thoraxjnl-2012-202592","article-title":"Efficacy and safety of adjunctive anticoagulation in patients with lung cancer without indication for anticoagulants: a systematic review and meta-analysis","volume":"68","author":"Zhang","year":"2013","journal-title":"Thorax"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006466.pub4\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:49:49Z","timestamp":1746254989000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006466.pub4"}},"subtitle":[],"editor":[{"given":"Elie A","family":"Akl","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,4]]},"references-count":77,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006466.pub4","relation":{},"subject":[],"published":{"date-parts":[[2014,6,4]]}}}